Senators Demand Pricing Details On $1000-Per-Pill Sovaldi

Two U.S. Senators on Friday asked biopharmaceutical company Gilead Sciences Inc. for more information on how it prices its hepatitis C medication Sovaldi, which has become a lightning rod for criticism of soaring pharmaceutical costs. ...read more

  • Tags: